CI

At a glance

ClinicalIndex Comparison Record
N/AUnknown· 180 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03039062
NCT03039062N/AUnknown
CompareCT.gov

Serum miR-122 as a Real-time Detection Biomarker of Drug-induced Liver Injury by Chemotherapy. - an Open , Multicenter, Non-interventional Clinical Trial

Chinese Academy of Medical Sciences·observational·Posted Feb 1, 2017·Updated Mar 30, 2017

In Brief

An observational study for Chemotherapeutic Toxicity and 2 related conditions. Targeting 180 participants across 1 site.

Detailed Summary

This is an open , multicenter, interventional clinical trial to conform the role of of miR-122 a real-time detection biomarker of drug-induced liver injury by chemotherapy.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsChemotherapeutic Toxicity, Malignant Tumor, Liver Injury
CountriesChina
Collaborators--

Timeline

N/AUnknownOverdue
2017201820192020202120222023202420252026
First PostedFeb 1, 2017
Enrollment StartJul 1, 2016
Primary CompletionJul 1, 2017
TodayJul 1, 2026
Enrollment to primary: 1 yearPosted 9.4 years ago